List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. Asia Pacific CRISPR Gene Editing Market, 2021-2031, $ mn 20
Figure 5. Categories of CRISPR-Cas Systems 21
Figure 6. Impact of COVID-19 on Business 25
Figure 7. Primary Drivers and Impact Factors of Asia Pacific CRISPR Gene Editing Market 27
Figure 8. Leading Causes of Death in the World, 2019-2020, million 33
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 34
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 34
Figure 11. Primary Restraints and Impact Factors of Asia Pacific CRISPR Gene Editing Market 36
Figure 12. Investment Opportunity Analysis 40
Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific CRISPR Gene Editing Market 43
Figure 14. Breakdown of Asia Pacific CRISPR Gene Editing Market by Offering, 2021-2031, % of Revenue 48
Figure 15. Asia Pacific Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 48
Figure 16. Asia Pacific CRISPR Gene Editing Market by Offering: CRISPR Products, 2021-2031, $ mn 49
Figure 17. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Kits & Enzymes, 2021-2031, $ mn 51
Figure 18. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Databases & Libraries, 2021-2031, $ mn 52
Figure 19. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Design Tools, 2021-2031, $ mn 53
Figure 20. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Antibodies, 2021-2031, $ mn 54
Figure 21. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: CRISPR Plasmid & Vector, 2021-2031, $ mn 55
Figure 22. Asia Pacific CRISPR Gene Editing Market by CRISPR Products: Other Products, 2021-2031, $ mn 56
Figure 23. Asia Pacific CRISPR Gene Editing Market by Offering: CRISPR Services, 2021-2031, $ mn 57
Figure 24. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: gRNA Design & Vector Construction, 2021-2031, $ mn 59
Figure 25. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: Cell Line Engineering, 2021-2031, $ mn 60
Figure 26. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: Microbial Gene Editing, 2021-2031, $ mn 61
Figure 27. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: DNA Synthesis, 2021-2031, $ mn 62
Figure 28. Asia Pacific CRISPR Gene Editing Market by CRISPR Services: Other Services, 2021-2031, $ mn 63
Figure 29. Breakdown of Asia Pacific CRISPR Gene Editing Market by Application, 2021-2031, % of Sales Revenue 65
Figure 30. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 65
Figure 31. Asia Pacific CRISPR Gene Editing Market by Application: Biomedical Research & Therapy, 2021-2031, $ mn 66
Figure 32. Asia Pacific CRISPR Gene Editing Market by Biomedical Research & Therapy: Gene Therapy, 2021-2031, $ mn 68
Figure 33. Asia Pacific CRISPR Gene Editing Market by Biomedical Research & Therapy: Drug Discovery, 2021-2031, $ mn 69
Figure 34. Asia Pacific CRISPR Gene Editing Market by Biomedical Research & Therapy: Diagnostics, 2021-2031, $ mn 70
Figure 35. Asia Pacific CRISPR Gene Editing Market by Biomedical Research & Therapy: Other Biomedical Applications, 2021-2031, $ mn 71
Figure 36. Asia Pacific CRISPR Gene Editing Market by Application: Agriculture, 2021-2031, $ mn 72
Figure 37. Asia Pacific CRISPR Gene Editing Market by Application: Industrial Use, 2021-2031, $ mn 73
Figure 38. Asia Pacific CRISPR Gene Editing Market by Application: Other Applications, 2021-2031, $ mn 74
Figure 39. Breakdown of Asia Pacific CRISPR Gene Editing Market by End User, 2021-2031, % of Sales Revenue 76
Figure 40. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 76
Figure 41. Asia Pacific CRISPR Gene Editing Market by End User: Pharmaceutical Companies, 2021-2031, $ mn 77
Figure 42. Asia Pacific CRISPR Gene Editing Market by End User: Biotechnology Companies, 2021-2031, $ mn 78
Figure 43. Asia Pacific CRISPR Gene Editing Market by End User: Academic Institutions & Research Centers, 2021-2031, $ mn 79
Figure 44. Asia Pacific CRISPR Gene Editing Market by End User: Other End Users, 2021-2031, $ mn 80
Figure 45. Breakdown of APAC CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue 82
Figure 46. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 83
Figure 47. CRISPR Gene Editing Market in Japan, 2021-2031, $ mn 85
Figure 48. CRISPR Gene Editing Market in China, 2021-2031, $ mn 87
Figure 49. CRISPR Gene Editing Market in Australia, 2021-2031, $ mn 89
Figure 50. CRISPR Gene Editing Market in India, 2021-2031, $ mn 92
Figure 51. CRISPR Gene Editing Market in South Korea, 2021-2031, $ mn 94
Figure 52. CRISPR Gene Editing Market in Rest of APAC, 2021-2031, $ mn 96
Figure 53. Growth Stage of Asia Pacific CRISPR Gene Editing Industry over the Forecast Period 98
Asia Pacific CRISPR Gene Editing market will grow by 28.6% annually with a total addressable market cap of $21.45 billion over 2022-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic. Highlighted with 35 tables and 53 figures, this 126-page report “Asia Pacific CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific CRISPR Gene Editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific CRISPR Gene Editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Country. Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • CRISPR Products o Kits & Enzymes § Vector-Based Cas9 § DNA-Free Cas9 o Databases & Libraries o Design Tools o Antibodies o CRISPR Plasmid & Vector o Other Products • CRISPR Services o gRNA Design & Vector Construction o Cell Line Engineering o Microbial Gene Editing o DNA Synthesis o Other Services Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Biomedical Research & Therapy o Gene Therapy o Drug Discovery o Diagnostics o Other Biomedical Applications • Agriculture • Industrial Use • Other Applications By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharmaceutical Companies • Biotechnology Companies • Academic Institutions & Research Centers • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Offering, Application, and End User, over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abcam, Inc. Agilent Technologies, Inc. Applied StemCell, Inc. Caribou Biosciences, Inc. Cellecta, Inc. CRISPR Therapeutics AG Editas Medicine, Inc. GeneCopoeia, Inc. GeneScript Biotech Corporation Horizon Discovery Group PLC Integrated DNA Technologies, Inc. Intellia Therapeutics Inc. Lonza Group Ltd. Merck KGaA New England Biolabs, Inc. Origene Technologies, Inc. Rockland Immunochemicals, Inc. Synthego Corporation System Biosciences LLC Takara Bio, Inc. Thermo Fisher Scientific, Inc. ToolGen, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More